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Abstract
Background: To determine the correlation between obesity in school-aged children and imbalance of gut microbes
by examining the ratio change of intestinal Bifidobacteria and E.coli in obese children compared to non-obese controls.
Methods: A hospital-based 1:1 case–control study was performed. Fecal samples of the subjects were collected for
DNA extraction and analyzed by quantitative real-time PCR (qPCR) to determine the copy number of Bifidobacteria and
E.coli. The ratio of two microbes (B/E) was then calculated and statistically analyzed.
Results: Subjects of the obesity group and control group showed no significant difference in age, gender or height
(P > 0.05); whereas they had significant differences in body weight and BMI. Copy numbers of Bifidobacteria and E.coli
per gram of wet fecal samples were first determined using qPCR in both obese and normal groups, which were further
used for the calculation of B/E ratio. We found that B/E ration in the two groups showed significant difference (P < 0.05).
Corrected χ2 test was performed for the two groups against B/E < 1, and it was found that there was a positive
correlation (OR = 719.2, OR 95% C.I. = 81.57-6341.18) between B/E ratio decrease with childhood obesity.
Conclusions: The obese children have a lower amount of Bifidobacteria and higher amount of E.coli (smaller B/E ratio)
compared to normal non-obese children. It was suggested that obesity in children may be associated with the imbalance
of gut microbes.
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Background
Obesity is the excessive accumulation of fat all over the
body due to a variety of factors. The impact of obesity
on metabolism, endocrine, function of the cardiovascu-
lar, respiratory and digestive systems as well as on the
growth and development of the body has been well stud-
ied [1]. Childhood obesity is closely correlated with adult
obesity, diabetes, hyperlipidemia, hypertension and cor-
onary heart disease. In recent years, with the improve-
ment in people’s living condition and the changes in diet
and other factors, childhood obesity is increasingly
prevalent and occurs in younger children [2,3]. Among
the non-genetic risk factors of obesity, the role of gut
microbes has been recognized. The correlation between
obesity and changes in gut microbes has been demon-
strated in multiple studies using animal models of obes-
ity, diabetes and other diseases [4-6]. In addition, it has
been shown that E. coli numbers were higher in women
with excessive weight gain than in women with normal
weight gain during pregnancy. In contrast, Bifidobacter-
ium and Akkermansia muciniphila showed an opposite
trend [7]. Thus far, the correlation between obesity in chil-
dren and gut microbes has been scarcely well studied, and
the significance of the ratio of intestinal Bifidobacteria and
E.coli (B/E ratio) remains to be defined. The current
hospital-based 1:1 case–control study examined the ratio
changes of intestinal Bifidobacteria and E.coli in obese and
non-obese school-aged children using quantitative real-
time PCR. Our data indicate that there was a positive cor-
relation between obesity and imbalance of gut microbes.
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Methods
Subjects and study groups
This study has been conducted with written approval
from the ethics committee of West China University
Second Hospital and written consent from both subjects
and their parents/guardians.
This study was a hospital-based 1:1 case–control with
random sampling. Inclusion criteria included: obese
group subjects were recruited from children visited
Child Health Clinic of West China University Second
Hospital from February 2012 to June 2012 and diag-
nosed with obesity according to the WHO/NCHS stand-
ard [8,9]; and non-obese control subjects were recruited
from these with a record of the annual health examin-
ation during the same period and in the same hospital
without a diagnosis of obesity. The obese and control
children were paired according to age and gender. Exclu-
sion criteria included antibiotics or probiotics receiving,
or a history of diarrhea or other gastrointestinal diseases
in the past 4 weeks; heart, lung, liver, kidney, endocrine,
genetic and metabolic diseases; or unwillingness to par-
ticipate in this study.
Age, gender and other general information of the sub-
jects were recorded; height (m) and weight (kg) of sub-
jects of the two groups were measured; fecal samples of
all subjects were collected with sterile and sealed box
within two hours after defecation, and immediately
stored at −70°C for further preparation.
Experimental methods
The experimental procedure included: preparation of
standard stains (revival, culture, passage, storage and
DNA extraction), extraction of DNA from fecal samples,
determination of DNA concentration and purity, primer
design for detection of specific microbe strains, estab-
lishment of standard curve with standard strain DNA,
and Quantitative real-time PCR (qPCR) analysis of the
samples, which is was carried out following manufac-
turer’s instructions.
The primers were synthesized by TaKaRa. Primer se-
quences of forward (F) and reverse (R) used in this study
are as follows. F: 5′-TTGGGCGTAAAGGGCTCGTA-3′,
and R: 5′-TTCGCCATCGGTGTTCTTCC-3′ for Bifido-
bacteria, which produce a PCR product with the length of
166 bp. F: 5′-GTTAATACCTTTGCTCATTGA-3′ and R:
5′-ACCAGGGTATCTTAATCCTGTT-3′for E.coli with a
144 bp PCR product.
Quantitative fluorescence PCR analysis of the samples:
sample DNA was extracted, and amount of Bifidobacteria
and E.coli 16 s rRNA was determined by quantitative
fluorescence PCR analysis using the same reaction system
and conditions as establishment of the standard curve.
Ten-fold serial dilutions of the standard and fecal bacteria
DNA samples were co-currently tested. Standard and
blank controls were included in each experiment, and each
sample was tested in triplicate. Specificity of the PCR reac-
tion was confirmed by the melting curve, and copy number
of the bacterial gene was calculated using Ct value and the
standard curve. Data were presented as the logarithm of
copy number (x lgx ± slgx), and ratio of Bifidobacteria to
E.coli (B/E) was calculated.
Statistical analysis
Data were analyzed using the SPSS software package.
Quantitative data were presented as mean ± standard de-
viation (x ± sd). Comparison was performed using two-
tailed t-test. Categorical data were compared using 2 ×
2-table χ2 test (Yates’ χ2 test or Fisher exact test was
used when the criteria were not met). Odd Ration (OR)
value and 95 % C.I. were calculated. P < 0.05 was consid-
ered statistically significant.
Results
General information: both obesity group and control
group included 63 subjects (Table 1). Two groups
showed no significant difference in age, gender and
height (P > 0.05), whereas they had significant difference
in body weight and BMI (P < 0.05).
Determination of DNA concentration and purity:
A260/A280 value of standard DNA was 1.83 ± 0.17 for
Bifidobacteria and 1.86 ± 0.13 for E.coli; A260/A280
value of the extracted DNA was 1.92 ± 0.28 for the obes-
ity group and 1.89 ± 0.26 for the control group. No sig-
nificant difference of DNA concentration and purity was
detected between the two groups (P > 0.05).
Quantitative real-time PCR results of the fecal samples
(Fig. 1, data were presented as the logarithm of copy
number (x lgx ± slgx).
Based on whether the B/E ratio value is lower than 1, dis-
tribution of subjects of the two groups were filled into a
2 × 2 table (Table 2). Because n > 40 and 1 ≤T < 5,Yates’ χ2
test was used. The results showed χ2 = 99.96, γ = 1, P <
0.0001, indicating a significant difference between obes-
ity and control groups; Our further calculation indi-
cated OR = 719.2 with a 95%C.I. of 81.57 ~ 6341.18. It
was suggested that there is a positive correlation
between obesity and B/E < 1.
Table 1 The general information of subjects (x ±s, n).
Obesity (n = 63) Control (n = 63)
Male 32 31
Female 32 31
Age 6.8 ± 2.1 6.8 ± 2.4
Height (m) 1.25 ± 0.11 1.20 ± 0.15
Weight (kg) 35.4 ± 5.8 24.0 ± 2.3
BMI (kg/m2)* 23.2 ± 5.2 15.2 ± 1.6
*BMI (BodyMass Index) = weight (kg)/height2 (m2).
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Discussion
As reported by WHO in recent past years, childhood
obesity is rapidly increasing globally and the incidence
of obesity has doubled since 1980, and over 40 million
children are currently living with obesity [9]. While the
pathogenesis of obesity is not clearly defined, the roles
of gut microbes has been proposed [1,10]. In a rat
model, it has been demonstrated that obesity can be
transferred by gut microbes: rats received gut microbes
from obese donor showed obesity but not slim donor
[11]. Accumulating data in the literature support the
idea that gut microbes, the largest and the most import-
ant micro-ecological system in human body, plays a sig-
nificant role in health. Under normal circumstances,
bacteria in the intestine maintain a certain proportion of
species and amount to sustain the stability of intestinal
micro-ecology. However, such stability could be dis-
turbed by a variety of factors, including metabolism, im-
mune system as well as the inflammatory reactions of
the host, and subsequently results in obesity and other
diseases [12-14]. In the mean time, gut microbiota is
under influence of physiological conditions, diet and
medication. For example, antibiotics [15], pregnancy
[16] or by probiotics [17,18] causes weight gain through
modulating gut flora. However, very limited data are
available in the literature regarding gut microbes and
childhood obesity. It becomes particularly important to
study relationship between gut microbes and obesity be-
cause of the rapid increase of childhood obesity. The
traditional method for identification and quantification
of fecal bacteria is culturing approaches, which is time-
and labor-consuming, and the results may vary due to
different operations. With the advance of molecular bio-
logical techniques, culture-free methods have emerged.
Currently, the 16 s rRNA-based qPCR is widely used in
micro-flora studies because of its high accuracy and sen-
sitivity as well as low chance of contamination [19,20].
In the current hospital-based 1:1 case–control study,
fecal DNA were prepared from obese and normal control
subjects and examined along with the DNA of standard
stains. A260/A280 of these DNA was determined to be
1.6-1.8, indicating good quality of the extracted DNA.
Standard DNA was prepared using standard strains and
tested by conventional PCR and quantitative fluorescent
real-time PCR to establish the standard curve. Primers
had good specificity for examined stains, as indicated by
results of conventional PCR and melting curve. Quantita-
tive fluorescent real-time PCR was further used to quan-
tify intestinal Bifidobacteria and E.coli content, and the
results showed that the obese children had significantly
lower content of Bifidobacteria and higher content of
E.coli, compared to normal control. It was suggested that
imbalance of gut microbes was present in these obese chil-
dren. Ratio of intestinal Bifidobacteria and E.coli (B/E)
was first introduced by Dutch scholar Van Der Waaij et al.
[21] to represent colonization resistance of gut microbes.
Bifidobacteria is a typical beneficial bacterium of the intes-
tine, while E.coli, a representative pathogenic bacterium.
Decrease in B/E is considered as an important indicator
for the shifting from normal gut microbes to an adverse
condition to health. Because these two types of bacteria
are also normal part of gut microbe flora, the B/E ratio
represents the overall condition of intestinal micro-flora
[22]. In this study, B/E ratio was significantly lower in
obese children than in normal controls, and there was a
strong correlation between obesity and B/E < 1, which are
consistent with the studies conducted by Million [18] and
Santacruz [7] in animal model and other populations.
Taken together, lower Bifidobacteria colonization and im-
balance of gut microbes may play an important role in the
development of obesity.
Conclusions
In summary, the correlation between obesity and gut mi-
crobes has been one of the hottest research topics. Stud-
ies on gut microbes have achieved substantial advances
using animal models. More investigations are necessary
to clearly defined its roles in human obesity. The B/E ra-
tio is a widely used parameter for estimating the overall
condition of gut flora. However, gut microbes consist of
large and complex system. Further study for the whole
spectrum of their functions and mechanisms in healthy
and pathological conditions may provide therapeutic tar-
gets of the treatment of obesity.
Fig. 1 Quantitative real-time fluorescent PCR results for fecal specimen
DNA content of Bifidobacteria and E.coli (x lgx ± slgx,copy number/g)
and their ratio in obese and normal subjects. (*, P < 0.05)
Table 2 The B/E ratio distribution in obese and normal groups
n (%)
B/E ratio < 1 B/E ratio≥ 1 Total
Obesity 58 (92.06) 5 (7.94) 63
Control 1 (1.59) 62 ((98.41) 63
Total 59 67 126
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